| Literature DB >> 25326117 |
Marek Wroński1, Włodzimierz Cebulski, Waldemar Pawłowski, Ireneusz W Krasnodębski, Maciej Słodkowski.
Abstract
BACKGROUND: Asymptomatic pancreatic necrosis should be managed conservatively, regardless of its extent. However, late sequelae and safety of non-interventional management in patients with asymptomatic walled-off necrosis remain unclear. AIMS: The purpose of this study was to report the clinical outcome of outpatient expectant management in a cohort of patients with walled-off necrosis who were discharged asymptomatic after an episode of acute pancreatitis.Entities:
Mesh:
Year: 2014 PMID: 25326117 PMCID: PMC4408372 DOI: 10.1007/s10620-014-3395-9
Source DB: PubMed Journal: Dig Dis Sci ISSN: 0163-2116 Impact factor: 3.199
The demographic and clinical characteristics of patients with asymptomatic WON at discharge after index acute pancreatitis
| Variable | Patients with complications | Patients asymptomatic during follow-up |
|
|---|---|---|---|
|
| 9 | 7 | |
| Male/female | 7:2 | 7:0 | 0.48 |
| Patient age (years) | 51 (36–65) | 54 (22–71) | 0.76 |
| Etiology: alcohol/other | 6:3 | 4:3 | 1.0 |
| CTSI (points) | 10 (6–10) | 9 (8–10) | 0.92 |
| Necrosis of pancreas: 0–50 %/above 50 % | 6:3 | 5:2 | 1.0 |
| Size of WON (mm) | 130 (85–200) | 140 (80–190) | 0.92 |
| Extension of WON: LS/R | 2:7 | 4:3 | 0.30 |
| WBC (×109/L) | 7.1 (4.0–16.2) | 7.4 (5.5–10.9) | 0.84 |
| CRP (mg/L) | 56.8 (8.7–245.2) | 16.8 (5.0–59.9) |
|
| Length of stay (days) | 34 (20–56) | 26 (13–54) | 0.30 |
Bold value indicates statistically significant
CTSI computed tomography severity index of acute pancreatitis, WON walled-off necrosis, LS limited to lesser sac, R extension to the pararenal regions, WBC white blood cell count, CRP C-reactive protein
Fig. 1a CT scan shows an area of walled-off necrosis in the lesser sac 32 months after the episode of acute pancreatitis. b Follow-up CT scan performed 9 months later revealed almost complete resolution of the necrotic collection. Gas bubbles (arrow) within the residual collection suggest its spontaneous decompression into the adjacent duodenum. This patient (case no 13) remained asymptomatic during the whole follow-up period
The late sequelae in patients with asymptomatic walled-off necrosis who underwent outpatient expectant management
| Case no. | Sex/age (years) | WON size (mm) | Time to discharge from the onset of AP (days) | Time to a complication after discharge (days) | Type of complication | Treatment of complication | Follow-up timea (months) | Residual necrotic collection |
|---|---|---|---|---|---|---|---|---|
| 1 | M/41 | 162 | 34 | 8 | IPN | PCD | – | – |
| 2 | M/36 | 127 | 20 | 180 | IPN | PCD | – | – |
| 3 | M/37 | 130 | 44 | 105 | IPN | PCD | – | – |
| 4 | F/51 | 200 | 41 | 74 | IPN | PCD, MARPN | – | – |
| 5 | M/57 | 130 | 21 | 47 | IPN | PCD | – | – |
| 6 | M/65 | 170 | 27 | 49 | IPN | Endoscopic cystogastrostomy | – | – |
| 7 | M/37 | 107 | 21 | 33 | IPN | PCD, Open necrosectomy | – | – |
| 8 | M/55 | 85 | 56 | 48 | Intracavitary hemorrhage | PCD, MARPN, open necrosectomy | – | – |
| 9 | F/64 | 124 | 34 | 105 | Pain, subileus | Open necrosectomy | – | – |
| 10 | M/22 | 141 | 43 | – | None | – | 9 | 2 collections: 80 and 70 mm |
| 11 | M/30 | 140 | 26 | – | None | – | 7 | Resolved |
| 12 | M/31 | 80 | 20 | – | None | – | 53.5 | 55 mm |
| 13 | M/54 | 190 | 54 | – | None | – | 41.5 | Resolved |
| 14 | M/61 | 110 | 13 | – | None | Open cystogastrostomy | 15.5 | – |
| 15 | M/61 | 124 | 19 | – | None | Open cystojejunostomy | 22 | – |
| 16 | M/71 | 180 | 26 | – | None | Endoscopic cystogastrostomy | 17 | – |
AP acute pancreatitis, IPN infected pancreatic necrosis, PCD percutaneous catheter drainage, MARPN minimal access retroperitoneal pancreatic necrosectomy
aRefers to patients who remained asymptomatic during follow-up
The spectrum of causative pathogens isolated from late infected pancreatic necrosis
| Case no. | Isolated pathogen from IPN | Characteristics of the pathogen | Antibiotic susceptibility of the pathogen |
|---|---|---|---|
| 1 |
| G+, facultative anaerobic, skin commensal, oral commensal (±) | Methicillin-sensitive |
|
| G−, anaerobic, oral commensal | Amoxicillin, clindamycin, metronidazole | |
| 2 |
| G+, anaerobic, oral commensal | Amoxicillin, clindamycin |
| 3 |
| G+, anaerobic, oral commensal | Amoxicillin, clindamycin |
| 4 |
| G−, facultative anaerobic, enteric bacillus | Ampicillin, ciprofloxacin, gentamicin, cephazolin |
|
| G−, anaerobic, enteric bacillus | Amoxicillin/clavulanate, clindamycin, metronidazole | |
|
| G+, anaerobic, oral, skin and GI commensal | Penicillin, clindamycin, metronidazole | |
| 5 |
| G+, microaerobic, oral commensal | Amoxicillin, clindamycin |
| 6 | Negative | – | – |
| 7 |
| G−, anaerobic, oral commensal | Amoxicillin/clavulanate, metronidazole (amoxicillin, clindamycin–resistant) |
|
| G+, microaerobic, oral commensal | Amoxicillin, clindamycin, erythromycin |
IPN infected pancreatic necrosis, G gram staining, GI gastrointestinal